Old Web
English
Sign In
Acemap
>
authorDetail
>
Jen Watts
Jen Watts
Novartis
Glaucoma
Ocular hypertension
Confidence interval
Maximum tolerated dose
Medicine
2
Papers
8
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Randomized, Controlled Phase I/II Study to Evaluate the Safety and Efficacy of MGV354 for Ocular Hypertension or Glaucoma
2018
American Journal of Ophthalmology
Rebecca C. Stacy
Kenneth Huttner
Jen Watts
James H. Peace
David Wirta
Thomas R Walters
Kenneth Sall
John J. Seaman
Xiao Ni
Ganesh Prasanna
Muneto Mogi
Christopher M. Adams
Jing-He Yan
Michael Wald
Yunsheng He
Ronald Newton
Randall Kolega
Cynthia L. Grosskreutz
Show All
Source
Cite
Save
Citations (8)
A phase I/II study to evaluate the safety, tolerability and early efficacy of MGV354 in healthy subjects and in patients with ocular hypertension or glaucoma
2018
Rebecca C. Stacy
Kenneth Huttner
Jen Watts
James H. Peace
David Wirta
Thomas R Walters
Kenneth Sall
John J. Seaman
Xiao Ni
Ganesh Prasanna
Muneto Mogi
Christopher M. Adams
Jing-He Yan
Michael Wald
Yunsheng He
Ronald Newton
Randall Kolega
Cyndy Grosskreutz
Show All
Source
Cite
Save
Citations (0)
1